Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn's Disease

Paul Rutgeerts*, Brian G. Feagan, Gary R. Lichtenstein, Lloyd F. Mayer, Stefan Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Stephen B. Hanauer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

822 Scopus citations

Fingerprint Dive into the research topics of 'Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn's Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences